SAN RAFAEL, Calif.


,


July 20, 2022


/PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on

Wednesday, August 3


^rd

, at

4:30 p.m. ET

to discuss second quarter 2022 financial results and provide a general business update.

Dial-in Number


U.S. / Canada Dial-in Number: (800) 231-0316

International Dial-in Number: +1 (314) 696-0504

U.S. / Canada Replay Dial-in Number: (800) 645-7964

International Replay Dial-in Number: (757) 849-6722

Playback ID: 2361#

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website,

www.biomarin.com

. A replay of the call will be archived on the site for one week following the call.

About BioMarin


BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company’s portfolio consists of seven commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. For additional information, please visit

www.biomarin.com

.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2022-financial-results-conference-call-and-webcast-on-wednesday-august-3-at-430pm-et-301590347.html

SOURCE BioMarin Pharmaceutical Inc.